Answers are grounded in this paper and cite their sources.
Introduction: Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with heterogeneity in clinical presentation and associated comorbidities. Existing classification systems mainly assess severity and do not adequately capture phenotypic variation. We previously developed a 3-class phenotype model based on latent class analysis (LCA). The objective of this study was to externally validate the previously developed phenotypic LCA model in an independent group of patients. Methods: In this cross-sectional multicenter analysis, consecutive HS patients seen between January 2023 and December 2024 at three referral centers in Italy and Switzerland were included. Clinical, demographic, comorbidity, severity, treatment, and quality-of-life data were collected. Validation was performed by applying the original LCA model to the new dataset and comparing the classification with dermatologist judgement. In addition, new 3-class and 4-class LCA models were trained and compared. A freely accessible web application based on the original LCA model was also developed. Results: A total of 420 patients were included (55.7% females, mean age 32.4 years), with a similar distribution across Hurley disease stages. The mean disease duration was 10.1 years and the mean diagnostic delay 6.6 years. The original LCA assigned 8.6%, 32.6%, and 58.8% of patients to classes I, II and III, respectively. Dermatologists assigned 20.0%, 26.4%, and 33.3% to these classes, while 20.2% were non-classifiable. The agreement between the original LCA and dermatologist classification was fair (AC1=0.35; accuracy=55.2%). A new 3-class LCA again showed the most stable fit and partially reproduced the original structure (AC1=0.50). A 4-class model did not substantially improve agreement. Conclusion: The original LCA framework showed partial reproducibility and modest concordance with dermatologist-based classification. These findings support its use as a research-oriented framework to structure HS heterogeneity, although further refinement and validation are needed before routine clinical implementation.
No takes yet. Share an insight, caveat, or question.
Cazzaniga et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: